![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 31835 |
FusionGeneSummary for RPL22_PRDM16 |
![]() |
Fusion gene information | Fusion gene name: RPL22_PRDM16 | Fusion gene ID: 31835 | Hgene | Tgene | Gene symbol | RPL22 | PRDM16 | Gene ID | 6146 | 63976 |
Gene name | ribosomal protein L22 | PR/SET domain 16 | |
Synonyms | EAP|HBP15|HBP15/L22|L22 | CMD1LL|KMT8F|LVNC8|MEL1|PFM13 | |
Cytomap | 1p36.31 | 1p36.32 | |
Type of gene | protein-coding | protein-coding | |
Description | 60S ribosomal protein L22EBER-associated proteinEpstein-Barr virus small RNA-associated proteinEpstein-Barr-encoded RNA-associated proteinheparin-binding protein 15heparin-binding protein HBp15large ribosomal subunit protein eL22 | PR domain zinc finger protein 16MDS1/EVI1-like gene 1PR domain 16PR domain containing 16transcription factor MEL1 | |
Modification date | 20180523 | 20180522 | |
UniProtAcc | P35268 | Q9HAZ2 | |
Ensembl transtripts involved in fusion gene | ENST00000484532, ENST00000234875, ENST00000497965, | ENST00000511072, ENST00000442529, ENST00000378398, ENST00000441472, ENST00000378391, ENST00000514189, ENST00000270722, ENST00000512462, | |
Fusion gene scores | * DoF score | 6 X 4 X 5=120 | 5 X 4 X 4=80 |
# samples | 6 | 5 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: RPL22 [Title/Abstract] AND PRDM16 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | PRDM16 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 19049980 |
Tgene | PRDM16 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 14656887 |
Tgene | PRDM16 | GO:0045892 | negative regulation of transcription, DNA-templated | 12816872 |
Tgene | PRDM16 | GO:0045893 | positive regulation of transcription, DNA-templated | 25578880 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SARC | TCGA-DX-AB2X-01A | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000484532 | ENST00000511072 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000484532 | ENST00000442529 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000484532 | ENST00000378398 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000484532 | ENST00000441472 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000484532 | ENST00000378391 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000484532 | ENST00000514189 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000484532 | ENST00000270722 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
5CDS-3UTR | ENST00000484532 | ENST00000512462 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000234875 | ENST00000511072 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000234875 | ENST00000442529 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000234875 | ENST00000378398 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000234875 | ENST00000441472 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000234875 | ENST00000378391 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000234875 | ENST00000514189 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000234875 | ENST00000270722 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
5CDS-3UTR | ENST00000234875 | ENST00000512462 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000497965 | ENST00000511072 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000497965 | ENST00000442529 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000497965 | ENST00000378398 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000497965 | ENST00000441472 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000497965 | ENST00000378391 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000497965 | ENST00000514189 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Frame-shift | ENST00000497965 | ENST00000270722 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
5CDS-3UTR | ENST00000497965 | ENST00000512462 | RPL22 | chr1 | 6257712 | - | PRDM16 | chr1 | 3342145 | + |
Top |
FusionProtFeatures for RPL22_PRDM16 |
![]() |
Hgene | Tgene |
RPL22 | PRDM16 |
Binds DNA and functions as a transcriptional regulator.Functions in the differentiation of brown adipose tissue (BAT)which is specialized in dissipating chemical energy in the form ofheat in response to cold or excess feeding while white adiposetissue (WAT) is specialized in the storage of excess energy andthe control of systemic metabolism. Together with CEBPB, regulatesthe differentiation of myoblastic precursors into brown adiposecells. Functions also as a repressor of TGF-beta signaling.Isoform 4 may regulate granulocytes differentiation.{ECO:0000269|PubMed:12816872, ECO:0000269|PubMed:14656887,ECO:0000269|PubMed:19049980}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for RPL22_PRDM16 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for RPL22_PRDM16 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
RPL22 | NSFL1C, CSE1L, CDC42, UBC, POU5F1, CD4, CALM1, MAPK14, RAD21, HDGF, ARRB1, ARRB2, NFX1, CUL3, CUL4A, CUL5, CUL2, CDK2, CUL1, COPS5, CAND1, PRAME, RPL15, RPL18, RPL19, RPL24, RPL37A, RPL14, RPS23, RPL11, RPL13, RPL4, RPS11, RPS13, RPS8, RPL6, RPL21, RPL27A, RPL5, RPL23A, RPS16, RPL7, RPL18A, RPS3A, RPL30, RPS26, RPS4X, RPS3, RPL7A, RPS6, RPS2, RPLP0, RPSA, RPS17, RPS24, RPS19, RPL23, RPL31, RPL12, RPL10A, RPS27A, RPS21, RPL17, ILF3, HNRNPM, RPS27L, RPL10L, STRAP, RPLP0P6, HSP90AA4P, DHX15, ESR1, SMURF1, VCAM1, FN1, IL7R, UBL4A, ITGA4, PAN2, CD81, IGSF8, ICAM1, SRPK2, TARDBP, PARK2, ARFGAP1, GTF3C4, HEXB, AURKA, CEP57, CEP76, TUBG1, VCP, HUWE1, PHF6, CCDC8, EED, RNF2, EGFR, LUZP4, WDR76, HNRNPU, LUC7L2, RPL10, RPL13A, ATP1B3, RPL38, RPL8, RPS12, RPS20, RPS5, RPL26, RPL26L1, RPL27, RPL3, RPL34, RPL35, RPL35A, RPL36, RPL9, RPLP2, RPS10, RPS14, RPS15, RPS15A, RPS18, RPS25, LOC101929876, RPS27, RPS7, RPS9, AHSA1, MYH9, NPM1, THOC5, NOP56, CBX8, MCM2, RC3H1, CDC73, NCL, CYLD, TRIM25 | PRDM16 | SMAD2, SMAD3, SKI, TFAP4, SPDEF |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RPL22_PRDM16 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for RPL22_PRDM16 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | PRDM16 | C0149931 | Migraine Disorders | 1 | CTD_human |
Tgene | PRDM16 | C3809288 | LEFT VENTRICULAR NONCOMPACTION 8 | 1 | ORPHANET;UNIPROT |